Clinical Trial Update: Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing CREWS01 for reducing rescue inhaler use in adults with moderate to severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CREWS01

Snippet

Sponsor: Global United Pharmaceutical Corporation | Conditions: Asthma | Phase 2 | Status: UNKNOWN